Publication & Citation Trends
Most Cited Works
Publications
63 total
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy PDF
Cited by 69
OpenAlex
Improved Long-Term Survival with Tafamidis Treatment in Patients with Transthyretin Amyloid Cardiomyopathy and Severe Heart Failure Symptoms PDF
Cited by 60
OpenAlex
Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study PDF
Cited by 40
OpenAlex
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy PDF
Cited by 188
OpenAlex
Natural History and Progression of Transthyretin Amyloid Cardiomyopathy: Insights from ATTR-ACT PDF
Cited by 44
OpenAlex
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]) PDF
Cited by 41
OpenAlex
Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study PDF
Cited by 205
OpenAlex
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy PDF
Cited by 116
OpenAlex
Research Topics
Amyloidosis: Diagnosis, Treatment, Outcomes
(55)
Peptidase Inhibition and Analysis
(23)
Coagulation, Bradykinin, Polyphosphates, and Angioedema
(18)
Parathyroid Disorders and Treatments
(17)
Pneumocystis jirovecii pneumonia detection and treatment
(11)
Frequent Co-Authors
Affiliations
Northwestern University
Pfizer (United States)
University of Pavia
Columbia University Irving Medical Center
University of Florida Health